LG Chem targets Japan with ‘Etanercept’ referencing Enbrel

LG Chem will aggressively target the Japanese ‘Etanercept’ market worth of KRW 400 billion.

When it comes to this news on the 30^th, LG Chem completed registering health insurance benefit price of ‘Etanercept BS, referencing etanercept(original product name: Enbrel) for the treatment of rheumatoid arthritis treatment, and has started to sell the products in Japan. ‘Etanercept BS’ is the first o...